Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-034590
Filing Date
2021-05-20
Accepted
2021-05-20 18:34:56
Documents
1
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3365
  Complete submission text file 0001209191-21-034590.txt   4757
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077
Business Address
SCHROFF MATTHIAS (Reporting) CIK: 0001737982 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39011 | Film No.: 21945957